http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004084914-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78e6f025e333bf49adc475e70569c7bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8287b8d98637425602d348d68934b66d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c55099f038b69a4a093b0d23bec4db3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cb4ab729c5c94a203059e5d3f32dbeb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
filingDate 2004-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a93765d3678ab5250a04a891c754b874
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf4668186e7d6a709c0254f74df51a22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2beafa963c7f866143816056037fffba
publicationDate 2004-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004084914-A1
titleOfInvention Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals
abstract The invention relates to the use of N-acetyl-D-aminoglycosamine and a pharmaceutically acceptable salt thereof in preparation of drugs for treatment of organ lesions related to toxicosis of drugs or chemicals. N-acetyl-D­aminoglycosamine as an active ingredient in formulations is used in treatment of organ lesions related to toxicosis of drugs or chemicals, with significant therapeutic effects and no side effects.
priorityDate 2003-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5217962-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0372730-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02067946-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2726
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB9GCH9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4694097
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE0ZS48
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO00084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23692432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22813375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24139
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO13465
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14210
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546955
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9SR52
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447796758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426033928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410432307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4432340
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519025
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CS22
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CS23
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP37063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410023599
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID584
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6A3P9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546193

Total number of triples: 56.